Please provide your email address to receive an email when new articles are posted on . Continuous BP monitoring with a cuffless device may provide sufficient data to accurately evaluate patient time ...
Nearly half of all adults in the U.S. have high blood pressure. "High blood pressure (also called hypertension) puts you at risk of many life-threatening problems," says Rachel Goodman, MD, Chief ...
Just a couple of months after announcing Rowatch D2, Rogbid is announcing its successor globally, called the Rowatch D3. Like ...
There are several blood pressure monitors on the market, but few reliable smartwatches with that functionality. Chinese tech brand Huawei's Watch D2 could change that. Huawei's Watch D2 includes an ...
Please provide your email address to receive an email when new articles are posted on . Collaborative telehealth visits and remote monitoring improved BP control and reduced hospitalizations. Patients ...
NEW YORK--(BUSINESS WIRE)--Nanowear, a leader in healthcare-at-home remote diagnostics, announced that its nanotechnology-enabled wearable and software platform, SimpleSense TM, has received FDA 510(k ...
Fitbit has outlined a new kind of blood pressure wearable in an updated patent filing recently published by the United States Patent and Trademark Office, as spotted by NotebookCheck. Google’s Fitbit ...
This type of cuffing season lasts all year long. High blood pressure, also known as hypertension, is a common problem that affects about 48% of US adults. An estimated 70% will experience it at some ...
Wearing a cuffless device on the wrist to continuously monitor blood pressure (BP) was associated with a significantly lower systolic BP at 6 months among hypertensive adults, real-world results from ...
SEOUL, South Korea, Sept. 25, 2025 /PRNewswire/ -- Sky Labs announced the official launch of CART BP, a ring-type personal blood pressure monitor designed for everyday use. Worn on the finger, CART BP ...
Data from 1566 patients were included in the meta-analysis ( Table I). The baseline demographics showed patients treated with placebo, telmisartan 40 or 80 mg, or comparators (losartan 50 mg, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback